Laquinimod
MS-LAQ-302E
Phase 3 small_molecule terminated
Quick answer
Laquinimod for Relapsing Multiple Sclerosis is a Phase 3 program (small_molecule) at Teva Pharma GmbH with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Relapsing Multiple Sclerosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated